Verve Therapeutics Earnings Estimate

VERV Stock  USD 6.23  0.07  1.11%   
By analyzing Verve Therapeutics' earnings estimates, investors can diagnose different trends across Verve Therapeutics' analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Verve Therapeutics is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Covid
Verve Therapeutics is projected to generate -0.61155 in earnings per share on the 31st of December 2024. Verve Therapeutics earnings estimates show analyst consensus about projected Verve Therapeutics EPS (Earning Per Share). It derives the highest and the lowest estimates based on Verve Therapeutics' historical volatility. Many public companies, such as Verve Therapeutics, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing Verve Therapeutics' earnings estimates, investors can diagnose different trends across Verve Therapeutics' analyst sentiment over time as well as compare current estimates against different timeframes. At this time, Verve Therapeutics' Gross Profit is fairly stable compared to the past year. Gross Profit Margin is likely to climb to 0.56 in 2024, whereas Pretax Profit Margin is likely to drop (17.84) in 2024.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Verve Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For more information on how to buy Verve Stock please use our How to Invest in Verve Therapeutics guide.

Verve Therapeutics Earnings per Share Projection vs Actual

About Verve Therapeutics Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Verve Therapeutics earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Verve Therapeutics estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Verve Therapeutics fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for Next Year
Retained Earnings-544.3 M-517.1 M
Retained Earnings Total Equity-309.8 M-325.3 M
Earnings Yield(0.22)(0.21)
Price Earnings Ratio(4.47)(4.70)
Price Earnings To Growth Ratio(0.62)(0.65)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Verve Stock Analysis

When running Verve Therapeutics' price analysis, check to measure Verve Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Verve Therapeutics is operating at the current time. Most of Verve Therapeutics' value examination focuses on studying past and present price action to predict the probability of Verve Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Verve Therapeutics' price. Additionally, you may evaluate how the addition of Verve Therapeutics to your portfolios can decrease your overall portfolio volatility.